Pharming Group N.V. presents its (unaudited) interim financial report for the first nine months and the third quarter ended 30 September 2019.

Pharming Group N.V. presents its (unaudited) interim financial report for the first half year ended 30 June 2019.

Pharming Webinar: halfjaarcijfers 2019 donderdag 25 juli 2019 tussen 19.00 en 20.00 uur. Nu aanmelden!

Pharming Group N.V. announces that at its Annual General Meeting of shareholders (AGM), held today, all proposals were approved. The presentation slides from today’s AGM are available on the Company’s website.

Pharming Group N.V. presents its (unaudited) interim financial report for the first quarter ended 31 March 2019.

Pharming Group N.V. announces that the Notice to Convene for its Annual General Meeting of Shareholders has been uploaded on its website. Pharming’s upcoming Annual General Meeting will be held at the Holiday Inn (Haagse Schouwweg 10, 2332 KG Leiden, The Netherlands) on 22 May 2019 at 14:00 CEST.

Pharming Group N.V. announces that following the Company’s announcement on 29 March 2019, it has completed its investment of €1.6 million in cash and conversion of €2.5 million of prepayments into new equity in its Fill & Finish partner BioConnection BV, which manufactures the sterile sealed vials of Pharming’s product RUCONEST® from the purified drug substance.

Pharming Group N.V. announces publication of its Annual Report for the financial year ended 31 December 2018. The Company also announces that it has made a provisional commitment to invest up to €1.6 million in cash and convert €2.5 million of prepayments into equity in its fill & finish partner BioConnection BV, which manufactures the final sealed vials of Pharming’s product RUCONEST® from the purified drug substance.

Pharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended 31 December 2018.

Pharming Webinar: Jaarcijfers 2018 donderdag 7 maart 2019 tussen 19.00 en 20.00 uur. Nu aanmelden!